DUBLIN–(BUSINESS WIRE)–The report “Regenerative Medicine Market by Product Type, Material, Application, and End-User (Hospitals, Ambulatory Surgical Centers, and Others: Global Opportunity Analysis and Industry Forecast, 2021-2030”) was added to from ResearchAndMarkets.com offer.

Regenerative Medicine Market size was valued at USD 10,107.32 Million in 2020 and is projected to reach USD 83,196.72 Million by 2030, growing at a CAGR of 23.4% from 2021 to 2030 .

Regenerative medicine is the process of replacing human cells, tissues or organs to restore or establish normal function. It is a field that brings together experts in biology, chemistry, genetics and medicine. This is a promising field that works to restore the structure and function of damaged tissues and organs.

It includes cell therapy involving the use of cellular materials such as stem cells, autologous cells, xenogeneic cells, and others, for the therapeutic treatment of patients. Cell therapy is used to replace damaged cells, deliver therapies to target tissues/organs, stimulate self-healing, and various other applications in regenerative medicine.

Major factors driving the growth of the regenerative medicine market include technological advancements in tissue and organ regeneration, increasing prevalence of chronic diseases and traumatic emergencies, significant potential of nanotechnology, and emerging stem cell technology.

Additionally, increasing incidence of degenerative diseases and shortage of organs for transplantation are expected to drive the market growth. The significant potential of regenerative medicine to replace, repair and regenerate damaged tissues and organs has fueled the growth of the market. Additionally, technological advancements in the production of regenerative medicine and advancements in stem cell therapy procedures are propelling the growth of the market.

Rising prevalence of musculoskeletal diseases and increase in dermatological treatments propel the growth of the market. Additionally, the use of nanomaterials in wound care, drug delivery, and immunomodulation has opened growth avenues for the regenerative medicine market.

However, stringent regulations, operational inefficiencies and high cost of regenerative medicine treatments are key factors hindering the growth of the market. Additionally, advancements in stem cell technology and increasing R&D activities in emerging economies are expected to fuel the market growth over the forecast period. Developed countries have embraced technological advancements in the tissue engineering and regenerative medicine sectors which are contributing to the expansion of the global market.

Additionally, accelerating development of pharmaceutical and medical device industries and improving healthcare expenditures are expected to drive the growth of the regenerative medicine market. Moreover, the rise in demand for regenerative medicine has led to the development of innovative technologies in the healthcare sector, thereby propelling the growth of the market.

Moreover, the initiatives taken by the governments for the development of advanced stem cell therapies and the development of the healthcare sector for manufacturing regenerative medicine are the key factors driving the growth of the market. Additionally, the increase in the geriatric population, which is more vulnerable to chronic diseases, is propelling the growth of the market.

KEY MARKET PLAYERS

• 3M

• Athersys Inc

• Cryo Life Inc

• Integra Life Sciences

• Isto Biologics

• Medtronic SA

• Organogenesis

• Stryker Company

• American Stem Cells Inc.

• Zimmer Biomet Holdings Inc.

KEY MARKET SEGMENTS

By product type

• Cell therapy

• Genetical therapy

• Creation of fabrics

• Small Molecule & Biological

By material

• Synthetic material

• Biodegradable synthetic polymer

• Scaffold

• Artificial vascular graft material

• hydro gel material

• Material of biological origin

• collagen

• Xenogenic material

• genetically modified material

• Deoxyribonucleic acid transfection vector

• genetically manipulated cell

• Three-dimensional polymer technology

• Pharmaceutical

• Small Molecule

• Biological

By app

• Cardiovascular

• Oncology

• Dermatology

• Musculoskeletal

• Wound healing

• Ophthalmology

• Neurology

• Others

Per end user

• Hospitals

• Ambulatory Surgery Center

• Others

By region

• North America

• WE

• Canada

• Mexico

• Europe

• Germany

• France

• UK

• Italy

• Spain

• The rest of Europe

• Asia Pacific

• Japan

• China

• India

• Australia

• South Korea

• Rest of Asia-Pacific

• LAMEA

• Brazil

• Saudi Arabia

• South Africa

• Rest of LAMEA

For more information about this report visit https://www.researchandmarkets.com/r/qek5u